Maéva Guillaume

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

Sven Francque, Pierre Bédossa, Vlad Ratziu et al. · New England Journal of Medicine · 2021 · 721 citations · Full text

Medicine, Internal Medicine, Pharmacology +15

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

Mònica Pons, Salvador Augustín, Bernhard Scheiner et al. · The American Journal of Gastroenterology · 2020 · 243 citations · Full text

Medicine, Internal Medicine, Hepatology +14

RISK-BENEFIT RATIO OF SODIUM FLUORIDE TREATMENT IN PRIMARY VERTEBRAL OSTEOPOROSIS

N. Mamelle, Ristić Dušan, Jean‐Louis Martin et al. · The Lancet · 1988 · 237 citations

Medicine, Dental Public Health, Bone Metabolism +8

New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD

Jérôme Boursier, Maéva Guillaume, Vincent Leroy et al. · Journal of Hepatology · 2019 · 149 citations · Full text

Medicine, Internal Medicine, Pathology +12